Journal of Urgent Care Medicine

The ‘Test and Treat’ Shift: 2026

“Test and treat” legislation at the state level is transforming pharmacists from dispensers into providers, authorizing them to diagnose and prescribe for conditions like flu, strep, and COVID-19 without physician oversight. As the map illustrates, this model is now active in more than 20 “direct open market” states (green), with legislation pending in key “battleground” states (yellow). JUCM first reported this disruption in 2015, and now the strategic intent is finally meeting regulatory reality.1 As …

Dynamics Between Pharmacists and AMA Heat Up

The American Medical Association (AMA) has been consistently outspoken against proposed legislation looking to authorize pharmacists to leverage test results to directly diagnose patients. AMA warns that such “scope creep” is detrimental to patient health because an isolated lab test depicts only a snapshot of overall health, which is not enough to determine treatment. AMA stresses that pharmacists are not trained to diagnose patients, and it has defeated pharmacist-prescribing proposals in Alabama and Louisiana. Pushing …

Pharmacists With Prescribing Privileges: A New Class of Medical Practitioner

Alan A. Ayers, MBA, MAcc, is Practice Management Editor for JUCM, serves on the board of directors of the Urgent Care Association of America, and is Vice-President of Strategic Initiatives for Experity. Urgent message: State boards of pharmacy, the National Association of Boards of Pharmacy, and large national drugstore chains are pushing for regulatory changes that would enable pharmacists to diagnose medical conditions and prescribe a range of medications, creating a new class of health-care …

Login to JUCM